Michael Lane - 13 Feb 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
Issuer symbol
IDXX
Transactions as of
13 Feb 2025
Net transactions value
-$120,912
Form type
4
Filing time
18 Feb 2025, 21:43:29 UTC
Previous filing
16 Feb 2024
Next filing
08 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +160 +2.5% $0.000000 6,650 14 Feb 2025 Direct F1
transaction IDXX Common Stock Options Exercise $0 +204 +3.1% $0.000000 6,854 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +220 +3.2% $0.000000 7,074 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +301 +4.3% $0.000000 7,375 14 Feb 2025 Direct
transaction IDXX Common Stock Tax liability $120,912 -272 -3.7% $444.53 7,103 14 Feb 2025 Direct
holding IDXX Common Stock 592 13 Feb 2025 by spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +6,320 $0.000000 6,320 13 Feb 2025 Common Stock 6,320 $459.76 Direct F3
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +217 $0.000000 217 13 Feb 2025 Common Stock 217 $459.76 Direct F4
transaction IDXX Restricted Stock Unit Award $0 +1,468 $0.000000 1,468 13 Feb 2025 Common Stock 1,468 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -160 -100% $0.000000 0 14 Feb 2025 Common Stock 160 Direct F6
transaction IDXX Restricted Stock Unit Options Exercise $0 -204 -50% $0.000000 204 14 Feb 2025 Common Stock 204 Direct F7
transaction IDXX Restricted Stock Unit Options Exercise $0 -220 -33% $0.000000 440 14 Feb 2025 Common Stock 220 Direct F8
transaction IDXX Restricted Stock Unit Options Exercise $0 -301 -25% $0.000000 903 14 Feb 2025 Common Stock 301 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 30, 2024 and December 31, 2024.
F2 Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
F4 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
F5 Grant of restricted stock units ('RSU') that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2026.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2022.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
F9 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.